243 related articles for article (PubMed ID: 10558891)
1. Formation of indigo by recombinant mammalian cytochrome P450.
Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of indole by cytochrome P450 enzymes.
Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
[TBL] [Abstract][Full Text] [Related]
3. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
5. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling.
Rosic NN; Huang W; Johnston WA; DeVoss JJ; Gillam EM
Gene; 2007 Jun; 395(1-2):40-8. PubMed ID: 17400405
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
7. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
8. Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH-cytochrome p450 reductase molecular interactions in living cells.
Ozalp C; Szczesna-Skorupa E; Kemper B
Drug Metab Dispos; 2005 Sep; 33(9):1382-90. PubMed ID: 15980100
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
[TBL] [Abstract][Full Text] [Related]
10. Drug metabolism by Escherichia coli expressing human cytochromes P450.
Parikh A; Gillam EM; Guengerich FP
Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
[TBL] [Abstract][Full Text] [Related]
11. Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells.
Wang MH; Patten CJ; Yang GY; Paranawithana SR; Tan Y; Yang CS
Arch Biochem Biophys; 1996 Oct; 334(2):380-8. PubMed ID: 8900414
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.
Locuson CW; Ethell BT; Voice M; Lee D; Feenstra KL
Drug Metab Dispos; 2009 Mar; 37(3):457-61. PubMed ID: 19074522
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of CYP102G4 from Streptomyces cattleya: A self-sufficient P450 naturally producing indigo.
Kim J; Lee PG; Jung EO; Kim BG
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):60-67. PubMed ID: 28821467
[TBL] [Abstract][Full Text] [Related]
15. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
16. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
17. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of P450 BM3 and glucose dehydrogenase by recombinant Escherichia coli and its application in an NADPH-dependent indigo production system.
Lu Y; Mei L
J Ind Microbiol Biotechnol; 2007 Mar; 34(3):247-53. PubMed ID: 17171348
[TBL] [Abstract][Full Text] [Related]
19. Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1.
Kim HR; Lee GH; Cho EY; Chae SW; Ahn T; Chae HJ
J Cell Sci; 2009 Apr; 122(Pt 8):1126-33. PubMed ID: 19339548
[TBL] [Abstract][Full Text] [Related]
20. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation.
Cuttle L; Munns AJ; Hogg NA; Scott JR; Hooper WD; Dickinson RG; Gillam EM
Drug Metab Dispos; 2000 Aug; 28(8):945-50. PubMed ID: 10901705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]